Parker Institute for Cancer Immunotherapy
@parkerici
Followers
11K
Following
4K
Media
979
Statuses
4K
Our mission is to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases.
San Francisco, CA
Joined February 2016
PICI is proud to co-author a new paper in @jitcancer alongside @CancerResrch, exploring the ways to advance genetically modified cell therapies for small & rare patient populations. Thank you to @John_E_Connolly, Crystal Mackall & PICI Research Team!
jitc.bmj.com
Genetically modified cell-based therapies hold transformative potential, particularly for patients with rare cancers and ultra-rare diseases. However, progress toward regulatory approval, reimburse...
0
2
6
This week, PICI was at @StanfordMed for the PICI at Stanford Medicine Scientific Strategy meeting. Grateful to connect with leaders @GoodZinaida @ansumansatpathy, @xrtcell, @ScienceKyle, @SRamakrishna_MD @RogelioHdezL, @GarryPNolan & others to advance cancer immunotherapy.
0
0
6
PICI is proud to support Dr. Lili Yang and @UCLA researchers developing an off-the-shelf CAR NKT cell therapy with strong potential against pancreatic cancer. Pre-clinical work shows it targets tumors where they spread and attacks with multiple mechanisms. https://t.co/0buKQoHLZ7
uclahealth.org
UCLA researchers have developed a CAR-NKT cell therapy that has shown to be more effective than current immunotherapies at fighting tumors in several different mouse models of pancreatic cancer.
0
3
14
We’re thrilled to announce @MarkVeich as PICI’s Chief Organizational Advancement Officer. Mark brings philanthropic and venture expertise that will support our mission to develop and deliver breakthrough cancer therapies. Join us in welcoming Mark to PICI! https://t.co/q6YOGjpXu6
0
1
6
We’re thrilled to celebrate @DrKarenKnudsen on being named a @FierceHealth 2025 Women of Influence honoree! At PICI, we work to develop breakthrough therapies to convert all cancers into curable diseases. Karen’s leadership drives that vision forward. https://t.co/jWGVEE92wz
1
2
15
Congrats to Carl June, Director of PICI Center @Penn, and PICI Collaborator Michel Sadelain of @Columbia, for the @BroermannAward. This honor recognizes Carl and Michel's trailblazing work in developing personalized cancer immunotherapy. Read more:
nature.com
Discover the world’s best science and medicine | Nature.com
0
2
14
This week, we are excited to join @WCM_MeyerCancer at the 2025 PICI - Weill Cornell Medicine Research Symposium, where researchers and leaders will discuss the latest in cancer immunotherapy, and share insights on adoptive cell therapy and checkpoint blockade.
0
0
4
More than two decades after FOXP3 was found to be key in immune balance, a discovery behind this year’s #NobelPrize, Alex Marson of @GladstoneInst @UCSF, & team reveal how it can be controlled, opening doors to new autoimmune & cancer therapies. Learn more: https://t.co/ZtveHMIdkF
gladstone.org
Scientists learn to fine-tune a gene that is centrally involved in regulating the immune system, offering potential clues for future autoimmunity and cancer treatments.
0
1
7
Proud to see PICI’s President of Research Ira Mellman receive SITC ’s “most prestigious award” this morning for his pioneering work & making a notable impact on the field. After accepting, he shared his perspective on the Coming Renaissance of Cancer Immunotherapy. #SITC25
0
1
15
This week, @DrKarenKnudsen joined a panel at @MilkenInstitute #MIHealthSummit, on the importance of scientific research & shared how PICI is helping the cancer immunotherapy field continue to thrive amidst uncertainty. #PICIatMIHealthSummit
0
0
2
At the @MilkenInstitute #MIHealthSummit, @DrKarenKnudsen spoke with industry leaders about the ways the research community can adapt and continue momentum amidst uncertainty and funding cuts. Watch the session: https://t.co/6TP9QfbJeO
#PICIatMIHealthSummit
0
1
5
The PICI network will be showing up in force at this week’s #SITC25 Annual Meeting to showcase the latest advances in #immunotherapy. Read more: https://t.co/O56kRUCOf9
0
0
5
Congrats to PICI researcher Dr. @j_eyquem on the launch of Azalea Therapeutics! His PICI-supported work laid the foundation for Azalea’s approach to engineer therapeutic cells inside the patient: transforming cell and gene therapy. https://t.co/aHHnlAvhxT
#PICI
globenewswire.com
Azalea Therapeutics launches with $82M to advance precision in vivo genome engineering, creating therapeutic cells directly inside patients....
0
2
15
In the final PICI #BCAM Research Spotlight, learn how researchers at @UCSF are helping accelerate immunotherapies for patients with breast cancer. Read more: https://t.co/SPivdJbVyF
0
0
5
CAR-T therapies have revolutionized blood cancer treatment, but have yet to transform triple-negative breast cancer. In this PICI #BCAM Research Spotlight, discover research from @WeillCornell to bring the power of CAR-T to breast cancer. Learn more: https://t.co/knSoO7gf6H
0
0
4
In this PICI #BCAM Research Spotlight, we’re sharing research from PICI collaborator institution @MDAndersonNews, where Dr. Kenneth Hu is exploring how to overcome barriers to #immunotherapy effectiveness in breast cancer and beyond.
0
0
1
In today’s #BreastCancerAwarenessMonth spotlight, discover research from @StanfordMed on how immune pathways influence breast cancer metastasis. More here: https://t.co/2Dt7VdrVN3
0
0
0
Dr. Ira Mellman, President of Research at PICI, delivered a keynote at AACR-NCI-EORTC #Targets25 on the coming renaissance of cancer immunotherapy & how PICI is accelerating research for patients. Photo©2025 American Association for Cancer Research® (AACR)/Todd Buchanan
0
1
6
This #BCAM, PICI is spotlighting scientific advances across the PICI Network that accelerate #breast cancer #immunotherapies. Today we focus on cancer vaccine and next-gen immunotherapy research from @PennMedicine. More here: https://t.co/69933Md3rZ
0
0
3
October is #BCAM, and PICI is highlighting scientific advances in cancer immunotherapy across the PICI Network. Today’s spotlight is on @DanaFarber. See the carousel for more & read about DFCI here: https://t.co/HqBI2HR676
0
0
5